Related Experiment Video
Updated: Apr 12, 2026

Investigating the Phagocytosis of Leishmania using Confocal Microscopy
Published on: July 29, 2021
Hemophagocytic lymphohistiocytosis in children with visceral leishmaniasis
Daniel Blázquez-Gamero1, Nerea Domínguez-Pinilla, Carmen Chicharro
1From the *Pediatric Infectious Diseases and Immunodeficiencies Unit, 12 de Octubre University Hospital, Madrid, Spain; †Pediatric Hematology/Oncology Unit, 12 de Octubre University Hospital, Madrid, Spain; ‡WHO Collaborating Centre for Leishmaniasis, Servicio de Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain; §Department of Pediatrics, Fuenlabrada University Hospital, Fuenlabrada, Spain; ¶Pediatric Infectious Diseases Unit, Hospital Infantil Universitario Niño Jesús, Madrid, Spain; ‖Department of Pediatrics, Severo Ochoa University Hospital, Leganés, Spain; **Department of Pediatrics, Getafe University Hospital, Getafe, Spain; ††Department of Pediatrics, Móstoles University Hospital, Móstoles, Spain; and ‡‡Department of Pediatrics, Ramón y Cajal University Hospital, Madrid, Spain.
Insights
Visceral leishmaniasis (VL) can cause acquired hemophagocytic lymphohistiocitosis (HLH) in children. This study found 41% of children with VL developed HLH, highlighting the need for VL screening in HLH cases from endemic regions.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Immunology
Background:
- Acquired hemophagocytic lymphohistiocitosis (HLH) is a severe hyperinflammatory syndrome.
- Visceral leishmaniasis (VL) is an emerging cause of secondary HLH, particularly in endemic areas.
- The frequency of HLH in pediatric VL cases requires further investigation.
Purpose of the Study:
- To determine the incidence of acquired hemophagocytic lymphohistiocitosis (HLH) in children diagnosed with visceral leishmaniasis (VL).
- To assess the clinical significance of VL as a trigger for HLH in pediatric populations.
Main Methods:
- A multicenter prospective study design was employed.
- Twenty-four children diagnosed with visceral leishmaniasis (VL) were enrolled.
- The development of HLH criteria was monitored in all participants.
Main Results:
- A significant proportion of children with VL developed HLH syndrome.
- Ten out of twenty-four (41%) pediatric VL patients met the criteria for HLH.
- This indicates a high frequency of HLH complication in this cohort.
Conclusions:
- Visceral leishmaniasis (VL) is a notable cause of acquired hemophagocytic lymphohistiocitosis (HLH) in children.
- Healthcare providers should consider and rule out VL in children presenting with HLH, especially those from or residing in endemic regions.
- Early diagnosis and management of VL may prevent or mitigate HLH development.
Abstract:
Acquired hemophagocytic lymphohistiocitosis (HLH) syndrome can be a complication of visceral leishmaniasis (VL). A multicenter prospective study was conducted to determine the frequency of HLH syndrome in children with VL. Twenty-four children with VL were identified, and 10 (41%) developed HLH syndrome. VL should be ruled out in all children with HLH criteria living in or coming from endemic areas.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lysosomal Hydrolases

